Antibiotic | Carrier (n = 55) | Infection (n = 51) | p value | Odds ratio (CI 95%) |
---|---|---|---|---|
Amikacin | 7 (12.7%) | 10 (19.6%) | 0.35 | 0.60 (0.20–1.74) |
Azithromycin | 26 (47.3%) | 27 (52.9%) | 0.57 | 0.80 (0.37–1.72) |
Cefoxitin | 55 (100%) | 51 (100%) | NA | NA |
Chloramphenicol | 53 (96.4%) | 49 (96.1%) | 0.94 | 1.08 (0.11–10.71) |
Ciprofloxacin | 27 (49.1%) | 31 (60.8%) | 0.24 | 0.62 (0.29–1.36) |
Clindamycin | 3 (5.5%) | 5 (0.1%) | 0.43 | 0.53 (0.10–2.44) |
Doxycycline | 21 (38.2%) | 19 (37.3%) | 0.92 | 1.04 (0.47–2.3) |
Erythromycin | 43 (78.2%) | 40 (78.4%) | 0.98 | 0.99 (0.38–2.52) |
Fosfomycin | 3 (5.5%) | 1 (0.02%) | 0.41 | 2.86 (0.29–77.36) |
Fusidic acid | 55 (100%) | 51 (100%) | NA | NA |
Gentamycin | 5 (9.1%) | 10 (19.6%) | 0.13 | 0.41 (0.12–1.30) |
Kanamycin | 38 (69.1%) | 41 (80.4%) | 0.19 | 0.55 (0.22–1.34) |
Levofloxacin | 8 (14.5%) | 10 (19.6%) | 0.50 | 0.70 (0.24–1.97) |
Linezolid | 0 (0%) | 0 (0%) | NA | NA |
Ofloxcacin | 7 (12.7%) | 9 (17.6%) | 0.50 | 0.68 (0.22–2.03) |
Oxacillin | 55 (100%) | 51 (100%) | NA | NA |
Vancomycin | 0 (0%) | 0 (0%) | NA | NA |
Quinu_Dalfo | 9 (16.4%) | 5 (0.1%) | 0.34 | 1.79 (0.56–6.31) |
Rifampicin | 2 (3.6%) | 1 (0.02%) | 0.66 | 1.88 (0.14–56.7) |
Sulphamethoxazol | 3 (5.5%) | 2 (0.04%) | 0.74 | 1.41 (0.20–12.27) |
Teicoplanin | 53 (96.4%) | 50 (98%) | 0.66 | 0.53 (0.02–7.19) |
Tetracycline | 36 (65.5%) | 36 (70.6%) | 0.58 | 0.79 (0.34–1.81) |
Tigecycline | 53 (96.4%) | 46 (90.2%) | 0.23 | 2.85 (0.54–22.1) |
Tobramycin | 4 (7.3%) | 7 (13.7%) | 0.30 | 0.50 (0.12–1.83) |